DuraTech will also provide surgeons with the clinical flexibility to cut,shape and suture the material to fit each patient's needs. Based on availabledata, Osteotech estimates that the market for dural repair substitutes isapproximately $100 million. In addition to the DuraTech BioRegeneration Matrix, which is expected tolaunch late this year, Osteotech plans to introduce additional humancollagen-based tissue products over the next several years that addresspatient needs and expand the addressable market for this innovativetechnology, including: rotator cuff repair, wound care applications andabdominal wall reconstruction. The DuraTech BioRegenerationMatrix is the lead product in Osteotech's collagen platform and is designed tobe utilized to repair the dura mater, a fibrous membrane that protects thebrain and the spinal cord, when the dura mater has been compromised due toinjury or surgery. Osteotech's proprietary collagen technology platform issupported by three pending patent applications. 
About Osteotech Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader inproviding OsteoBiologic solutions for regenerative medicine to supportsurgeons and their patients through the development of innovativetherapy-driven products that alleviate pain, promote regenerative and biologichealing and restore function. For further information regarding Osteotech orthis press release, please go to Osteotech's website at Certain statements made throughout this press release that are not historicalfacts contain forward-looking statements (as such are defined in the PrivateSecurities Litigation Reform Act of 1995) regarding the Company's futureplans, objectives and expected performance. Any such forward-lookingstatements are based on assumptions that the Company believes are reasonable,but are subject to a wide range of risks and uncertainties and, therefore,there can be no assurance that actual results may not differ materially fromthose expressed or implied by such forward-looking statements. Certainof these factors are detailed from time to time in the Company's periodicreports filed with the Securities and Exchange Commission.

All information inthis press release is as of January 7, 2009 and the Company does not intend toupdate this information SOURCEOsteotech, Inc.Mark H. Burroughs, 1-732-542-2800; or Media/Investors: Jennifer Beugelmans,1-646-596-7473, both of Osteotech, Inc.. An identity so clear that he developed an objective.The objective was to find his city's ring, but the path to get there was cruel.For years he fought his enemies for the ring but he could not conquer them. One time he got close, but he was defeated by the men of large lakes.After years offrustration he left on a new journey for the ring. His identity remained the same but the man who was once known as the answer became a question in himself.A question of struggle.A question of dominance.A question ofperseverance.And somewhere along this path, he lost his identity and then he lost his way home.So how do you like it so farI know, it's sad.This warrior had an objective his whole life. He poured his heart into making this objective into a reality.Try telling the other warriors practicing in their backyards even as you read these words that their dream is no more than a fantasy.You see, when you pour your heart into something, it makes things fuzzy and it can make you thinkunclear.He needed to move forward and took a big step in that by announcing his retirement from his journey of finding the ring.But then somethinghappened, an opportunityarisen.He was given the chance to come back to the city he started in, the city he poured his heart into.This was unexpected and surprising but he was given a choice.